Post by Claude Waddington

We’re past “AI vs. humans” in pharma. The real lever is the human–agent ratio: people set intent and governance; agents execute at scale. From Digital Pharma Advances 2026, five action-backed moves that make the ratio work in practice: 1. Trustworthy inputs before clever models—data contracts, lineage, and feedback loops. (Richard Jones at Pfizer) 2. Treat AI as a tool that augments judgment; keep humans in the loop on high-stakes steps. (Lyly F. at Sanofi) 3. Stop bespoke pilots; productize patterns and reuse components to compound learning. (Antonio Ibarra at Grünenthal Group Grünenthal Spain) 4. Personalization at scale runs on rules and guardrails, not guesswork; codify decisioning. (Sara Tea Di Niro at Teva Pharmaceuticals) 5. Governance + people + routines beat one-off heroics; institutionalize the operating rhythm. (Frédéric Baffou at Medtronic) My take: aim for humans to define intent, constraints, and accountability; let agents handle repeatable analysis, orchestration, and monitoring—with transparent handoffs and audit trails. The Palindromic team and I, have packaged the details in the attached carrousel: “5 Action-Backed Insights for Pharma Leaders.” What’s one routine your team has institutionalized that made AI both safer and faster? #DigitalPharma #AIinPharma #Omnichannel #HumanAI #PharmaInnovation